Despite considerable improvements in prevention and therapy, coronary artery disease (CAD) is still the major non-communicable disease world-wide and causes the greatest loss of healthy life-years worldwide, thus burdening the patients, their families and our society as a whole.
1,2 Cardiovascular prevention measures are more effective the earlier in disease onset they are initiated. On the other hand, rising healthcare costs and potential side effects require careful consideration of when to start which treatment in which patients. Both high sensitivity and specificity are therefore needed in diagnostic tools for early CAD detection.
Micro ribonucleic acids (miRs) -short ribonucleic acid sequences which do not encode a protein, but instead regulate the expression of several proteinshave been hailed as powerful novel biomarkers for a number of diseases, including CAD. Indeed, many studies have reported altered plasma levels of individual miRs in patients with established CAD. 3, 4 However, studies often disagree about the miRs reported and many miRs have been detected in various cardiovascular and metabolic diseases. 5, 6 No individual miR or set of miRs has been unanimously accepted as a reliable biomarker for early CAD in the field so far.
In addition to technical parameters, which can in principle be solved (standardization of pre-analytics and detection methods, pre-selection of miRs), patient-associated factors greatly influence the quality of information we can gain from miR studies. Those include the definition of study populations (i.e. we rely on established means of CAD detection to define 'CAD', which might mean we miss early stages or definition/assignment of groups/time points varies greatly) as well as inter-individual variations within the study group (i.e. influences of genetic background, lifestyle, medication, age and sex of the patient). Initial alterations of biomarkers at early stages might therefore be lost in the noise.
Statistical tools capable of analysing large numbers of variables/dimensions can be used to increase sensitivity, thereby identifying not only one individual miR, but a combination of several miRs. Those can be combined with functional readouts and classical biochemical markers, such as exercise capacity and highsensitivity cardiac troponin I (hs-cTnI). In addition, observing the response to a defined challenge in a controlled environment, such as an exercise test or dobutamine stress test, might be more informative than assessing only baseline levels.
A second clinical need can in principle be addressed by the same concept: while regular exercise training is an effective cardiovascular prevention measure, acute exercise can trigger cardiac ischaemia and cardiovascular events -especially in the untrained. If we had a set of diagnostic tools discerning a pathologic from a physiologic response to acute exercise, we might potentially identify those patients at risk early on.
In this issue of the European Journal of Preventive Cardiology, Mayr et al. present a study where they address these questions. The group challenged study participants -CAD patients or healthy controlswith an all-out exercise test and assessed patterns of miR up-or downregulation in response to this challenge. 7 The authors identified a combination of preand post-exercise levels of the miRs 150-5p, 101-3p, 141-3p and 200b-3p in addition to individual maximal oxygen uptake (VO 2max ) and the body weight-adjusted maximal power developed (P max-rel ) to be superior to only the combination of VO 2max and P max-rel in assigning the study participants to their respective study group.
Interestingly, the miRs reported here have only rarely been associated with cardiovascular diseases before, but were rather found to have tumour suppressor functions. [8] [9] [10] [11] [12] In addition, miR-141 and miR-200 belong to the same family and have been found co-regulated in other contexts -thus strengthening the concept of analysing patterns rather than individual miRs. 13 The findings also illustrate the potential of relatively large screening approaches in contrast to assessing only a limited number of pre-selected miRs, as was the case in a recent study aiming to address the same scientific question, but failing to identify differentially regulated miRs. 14 Can we deduce potential biological mechanisms from these findings? A number of biological processes -angiogenesis, cell energy metabolism and inflammation -are dysregulated in cardiovascular diseases as well as in cancer. Especially metabo-inflammatory processes might be shared by both pathological fields. The findings therefore underline the need to analyse and compare biological principles across a wider range of pathologies, especially if we aim to identify diagnostic tools for the heterogenous patient cohorts we are confronted with in everyday routine.
In contrast to more or less cell type-specific miRs, such as miR-1, miR-499 or miR-126, most miRs can be expressed by a number of cells. Their levels in the plasma might therefore represent a combined output of active and passive release of miRs from several tissues or organs. Plasma levels of a miR do not necessarily mirror its expression in the atherosclerotic plaque. 15, 16 In addition, differences in perfusion, at baseline and after exercise, will impact on the organspecific contribution to miR plasma levels. Finally, miR uptake by perfused tissues as well as excretion negatively affect plasma miR levels.
The complexity of this system bears benefits -miR plasma levels reflect the combined organ/tissue dysfunctions of a disease -but at the same time complicates the task to link back from the miR readouts in plasma to specific mechanistic dysfunctions: one always needs to consider a number of processes as well as their interaction potentially modifying the molecular response. New biostatistic methods and improved data storage and processing capacity will certainly accelerate hypothesis development here in the near future.
In addition, polymorphisms in miRs miR-146a, miR-499 and miR-196a have been found to impact on cardiovascular disease in a recent meta-analysis. 17 Hence, a possible bi-directional interaction between miR expression levels and cardiovascular disease status needs to be considered.
The study by Mayr et al. bears a number of limitations. One is the lack of a validation cohort. Another is the selection of patients: no group of early-onset patients was included, which would have addressed the aim to identify a miR pattern indicative of early stages of CAD, nor did any of the patients show signs of myocardial ischaemia (in fact, this was not tested) or cardiovascular events, which would have addressed the aim to identify a miR pattern indicative of patients at risk to develop exercise-induced cardiovascular events, as is stated in the abstract. 7 While power and oxygen uptake -measures of exercise capacity and fitness -were combined with the miR quantification in an innovative and comprehensible way, hs-cTnI (usually employed when studying exerciseinduced cardiac ischaemia) was not assessed. 7, 18 Taken together, miRs do have the potential to provide additional information on cardiovascular disease state, especially their alteration by a challengephysiological or pharmacological -as this might level out intra-individual differences and indicate early dysfunctions and may help to better understand personal cardiovascular risk. Combined scores integrating physiological readouts with biochemical ones might be a way forward to better represent the underlying biology.
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